Development and Validation of a Duplex qPCR Assay for the Detection of Residual Sf9 Host Cell DNA and Baculovirus DNA
WATCH NOW
In this webinar, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of low level Sf9 and Baculovirus DNA to help meet regulatory requirements.
Current regulatory authorities (WHO, EMA and US FDA) limited the accepted amounts of residual DNA in biological products making it extremely important to have a sensitive method of quantifying residual host cell DNA. Among the methods of detecting residual DNA, qPCR is the most widely used for residual DNA quantitation due to its sensitivity, accuracy, precision, and time-saving capability.
In this webinar, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of low level Sf9 and Baculovirus DNA to help meet regulatory requirements.
Watch now to learn about:
Summary of current regulatory requirements for residual host DNA clearance for biological products and what that means for gene therapy applications
Demonstration of a streamlined, automated workflow for quick quantification of residual Sf9 host cell DNA and helper baculovirus DNA
Performance specifications for the new Applied Biosystems resDNASEQ Quantitative Sf9 and Baculovirus DNA system
Speaker Information:
Dr Kara Norman Senior Manager, Research and Development, Pharmaceutical Analytics, Thermo Fisher Scientific
